Ebos Group (ASX:EBO) Other Long Term Assets: A$368 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:EBO Ebos Group Ltd ASX:EBO
73 GF Score
Price A$18.57
GF Value A$32.20
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Ebos Group Other Long Term Assets?

Ebos Group ASX:EBO -2.06% 73 Other Long Term Assets is A$368 Mil as of Jun. 2026. GuruFocus rates ASX:EBO with a GF Score™ of 73/100 and a GF Value™ of A$32.20 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Ebos Group's other long-term assets for the quarter that ended in Jun. 2026 was A$368 Mil.

Ebos Group's quarterly other long-term assets declined from Jun. 2025 (A$310 Mil) to Dec. 2025 (A$263 Mil) but then increased from Dec. 2025 (A$263 Mil) to Jun. 2026 (A$368 Mil).

Ebos Group's annual other long-term assets increased from Jun. 2024 (A$276 Mil) to Jun. 2025 (A$310 Mil) and increased from Jun. 2025 (A$310 Mil) to Jun. 2026 (A$368 Mil).

Ebos Group Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for Ebos Group's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ebos Group Other Long Term Assets Chart

Ebos Group Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 182.60 207.51 276.18 309.62 367.82

Ebos Group Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 276.18 241.46 309.62 263.07 367.82
ASX:EBO
73GF Score
Ebos Group Ltd ASX:EBO
Other Long Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ebos Group Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of A$368 Mil mean?
Ebos Group (ASX:EBO) has a Other Long Term Assets of A$368 Mil as of Jun. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Ebos Group and its competitors.
Is Ebos Group's Other Long Term Assets too high?
Ebos Group's current Other Long Term Assets is A$368 Mil. Overall, Ebos Group has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ebos Group's Other Long Term Assets compare to MCK and COR?
Ebos Group's Other Long Term Assets of A$368 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Medical Distribution company?
A good Other Long Term Assets depends on the Medical Distribution industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Ebos Group and its competitors. Ebos Group's current Other Long Term Assets is A$368 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ebos Group stock overvalued right now?
Based on GuruFocus' analysis, Ebos Group (ASX:EBO) is currently considered Significantly Undervalued. The stock's GF Value™ is A$32.20, compared to a current price of A$18.57 — trading 42.3% below its estimated fair value. The current Other Long Term Assets is A$368 Mil. Ebos Group's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For Ebos Group (ASX:EBO), the current Other Long Term Assets is A$368 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ebos Group (ASX:EBO) Overvalued in 2026?

Based on GuruFocus' analysis, Ebos Group stock appears to be undervalued. The current stock price of A$18.57 is trading 42.3% below its estimated GF Value™ of A$32.20. GuruFocus considers Ebos Group to be Significantly Undervalued.

Key valuation signals for ASX:EBO:

  • Other Long Term Assets: A$368 Mil
  • GF Value™: A$32.20 vs. price of A$18.57 (42.3% below fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the ASX:EBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ebos Group Business Description

Address 737 Bourke Street, Level 7, Docklands, Melbourne, VIC, AUS, 3008
Ebos is the largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
73GF Score

Get the complete analysis for ASX:EBO

Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$18.57
Price
A$32.20
GF Value